1. Home
  2. ETON vs BUJA Comparison

ETON vs BUJA Comparison

Compare ETON & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • BUJA
  • Stock Information
  • Founded
  • ETON 2017
  • BUJA 2022
  • Country
  • ETON United States
  • BUJA Malaysia
  • Employees
  • ETON N/A
  • BUJA N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • BUJA Blank Checks
  • Sector
  • ETON Health Care
  • BUJA Finance
  • Exchange
  • ETON Nasdaq
  • BUJA Nasdaq
  • Market Cap
  • ETON 199.5M
  • BUJA N/A
  • IPO Year
  • ETON 2018
  • BUJA 2023
  • Fundamental
  • Price
  • ETON $8.82
  • BUJA $10.96
  • Analyst Decision
  • ETON Strong Buy
  • BUJA
  • Analyst Count
  • ETON 3
  • BUJA 0
  • Target Price
  • ETON $12.00
  • BUJA N/A
  • AVG Volume (30 Days)
  • ETON 214.1K
  • BUJA 2.7K
  • Earning Date
  • ETON 11-11-2024
  • BUJA 01-01-0001
  • Dividend Yield
  • ETON N/A
  • BUJA N/A
  • EPS Growth
  • ETON N/A
  • BUJA N/A
  • EPS
  • ETON N/A
  • BUJA 0.29
  • Revenue
  • ETON $31,381,000.00
  • BUJA N/A
  • Revenue This Year
  • ETON $19.61
  • BUJA N/A
  • Revenue Next Year
  • ETON $35.39
  • BUJA N/A
  • P/E Ratio
  • ETON N/A
  • BUJA $37.13
  • Revenue Growth
  • ETON 8.14
  • BUJA N/A
  • 52 Week Low
  • ETON $3.03
  • BUJA $10.30
  • 52 Week High
  • ETON $8.66
  • BUJA $12.18
  • Technical
  • Relative Strength Index (RSI)
  • ETON 76.07
  • BUJA 67.66
  • Support Level
  • ETON $7.58
  • BUJA $10.85
  • Resistance Level
  • ETON $8.66
  • BUJA $10.85
  • Average True Range (ATR)
  • ETON 0.42
  • BUJA 0.00
  • MACD
  • ETON -0.07
  • BUJA -0.00
  • Stochastic Oscillator
  • ETON 91.49
  • BUJA 87.50

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About BUJA Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd is a blank check company.

Share on Social Networks: